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in vitro selection for adhesion 
of Plasmodium falciparum‑infected 
erythrocytes to ABo antigens 
does not affect PfEMP1 and RIFIN 
expression
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2, Rebecca W. Olsen 4, Nanna Dalgaard 4, Michael F. Ofori 1, Lars Hviid 3,4, 
Jørgen A. L. Kurtzhals 2,4 & trine Staalsoe 2,4*
Plasmodium falciparum causes the most severe form of malaria in humans. The adhesion of the 
infected erythrocytes (ies) to endothelial receptors (sequestration) and to uninfected erythrocytes 
(rosetting) are considered major elements in the pathogenesis of the disease. Both sequestration 
and rosetting appear to involve particular members of several IE variant surface antigens (VSAs) as 
ligands, interacting with multiple vascular host receptors, including the ABO blood group antigens. In 
this study, we subjected genetically distinct P. falciparum parasites to in vitro selection for increased 
IE adhesion to ABO antigens in the absence of potentially confounding receptors. The selection 
resulted in IEs that adhered stronger to pure ABO antigens, to erythrocytes, and to various human 
cell lines than their unselected counterparts. However, selection did not result in marked qualitative 
changes in transcript levels of the genes encoding the best-described VSA families, PfEMP1 and RIFIN. 
Rather, overall transcription of both gene families tended to decline following selection. Furthermore, 
selection-induced increases in the adhesion to ABO occurred in the absence of marked changes in 
immune IgG recognition of IE surface antigens, generally assumed to target mainly VSAs. Our study 
sheds new light on our understanding of the processes and molecules involved in IE sequestration and 
rosetting.
Malaria remains a major cause of infectious disease mortality and morbidity in many parts of the  World1. It is 
caused by haemo-protozoan parasites of the genus Plasmodium, which infect and multiply within erythrocytes. 
The formation of rosettes, which is the binding of multiple uninfected erythrocytes to a central infected eryth-
rocyte (IE), was first reported in the simian malaria parasite P. fragile2, but it is also common among human 
malaria  parasites3–7. In two of these, P. falciparum and P. vivax, rosetting has repeatedly been associated with 
severe  disease8–11, although the functional significance of rosetting is not fully  understood12.
Rosetting involves multiple parasite-encoded ligands and host erythrocyte  receptors13. Particular members of 
the three major parasite multi-gene families var (P. falciparum only)14–16, rif17,18, and stevor19 have been implicated 
as ligands, while a range of glycoproteins, proteoglycans, and carbohydrate moieties on the erythrocyte surface 
have been proposed as host receptors. These latter molecules include the blood group determinants A and  B20, 
 CD3621,22, heparan  sulphate23, complement receptor 1 (CR1)14, and glycophorin  C19,24. Soluble host proteins such 
as  IgM25–27 and α2-macroglobulin28 also appear critical for at least some forms of rosetting, adding further to the 
complexity of the rosetting phenotype.
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Blood group O (lack of blood group antigens A and B) has repeatedly been associated with protection from 
severe P. falciparum  malaria29,30. This suggests that IE adhesion to A or B antigen, on erythrocytes (rosetting) or 
on endothelium (sequestration), is a risk factor for development of severe malaria. Identification of the parasite 
ligand(s) mediating binding to these receptors is therefore of interest. To achieve that, we selected IEs for their 
ability to adhere to blood group A, B and O blood group oligosaccharides in vitro by repeated panning on these 
antigens immobilized to plastic via bovine serum albumin, and examined associated changes in transcription 
of parasite genes encoding putative adhesion ligands.
Results
Plasmodium falciparum-infected erythrocytes can be selected in vitro for binding to ABO 
blood group antigens. The blood group antigens A and B are formed by addition of a terminal α-1,3-N-
acetylgalactosamine or galactose residue, respectively, to the H antigen (blood group O). To test the ability of 
IEs to adhere to these antigens in the absence of interference from other potential adhesion receptors present on 
erythrocytes and endothelial cells, we used bovine serum albumin (BSA) neo-glycoproteins displaying A, B, or 
H antigens (BSA-A, BSA-B, and BSA-H) as receptors for IE adhesion. Whereas unselected erythrocytes infected 
by P. falciparum 3D7 bound only weakly to any of these antigens, selection for IE adhesion to either BSA-A or 
BSA-B resulted in IEs that bound significantly better to both receptors, whereas selection for IE adhesion to 
BSA-H had little effect (Fig. 1). Selection of four additional P. falciparum lines/clones yielded results similar to 
those obtained with 3D7 for two of them (FMG and FUP), whereas we were unable to improve the adhesion to 
blood group sugars of erythrocytes infected by P. falciparum FCR3 or HB3 (Supplementary Fig. 1).
The similar results obtained by IE panning on BSA-A and BSA-B prompted us to verify the uniqueness of 
the neo-glycoproteins used. Blood group A-specific antibody blocked adhesion of IEs to BSA-A, but had only 
limited effect on adhesion of the same IEs to BSA-B (Supplementary Fig. 2). In contrast, blood-group B-specific 
antibody efficiently inhibited adhesion of IEs to BSA-B, but had no effect on adhesion of the same IEs to BSA-A 
(Supplementary Fig. 2). These results confirm that the BSA-A and BSA-B neo-glycoprotein constructs were 
antigenically distinct. To assess the possibility that the shorter (three-atom) spacer used in the BSA-H construct 
than in the BSA-A and BSA-B constructs (six-atom spacer) negatively affected IE adhesion to BSA-H, we also 
tested IE adhesion to a BSA-B construct with a three-atom spacer (BSA-Bshort). Although selected P. falciparum 
3D7 bound less well to BSA-Bshort, similarly selected FMG IEs adhered equally well to either construct (Sup-
plementary Fig. 3). This suggests that the length of the spacer is of limited importance.
Overall, the experiments indicate that some, but possibly not all P. falciparum parasites can express ligands 
on the surface of IEs that enable their adhesion to the blood group carbohydrate antigens A and B.
Plasmodium falciparum-IEs selected for adhesion to A and B blood group antigens form 
rosettes with corresponding uninfected erythrocytes. Several studies have implicated ABO anti-
gens as receptors involved in the rosetting reaction around P. falciparum IEs. We therefore tested the impact on 
rosetting rates of selection for IE adhesion to ABO antigens. Without selection, rosettes did not form around 
Figure 1.  Selection for IE adhesion to ABO antigens. Adhesion of erythrocytes infected with late-stage P. 
falciparum 3D7 to BSA, BSA-H, BSA-A, and BSA-B before (white) and after four rounds of selection on BSA-H 
(grey), BSA-A (red), and BSA-B (blue), respectively. Adhesion of uninfected erythrocytes to the receptors was 
always < 5% of the erythrocytes added. Error bars indicate standard deviations of mean results from the number 
of independent assays indicated in the figure. Statistically significant differences (P < 0.05) of post-hoc pairwise 
comparisons (Holm-Sidak method) following 1-way ANOVA (P < 0.001) are indicated by lines along the top of 
the panel.
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erythrocytes infected by P. falciparum 3D7, FMG, or FUP, but selection of IEs for adhesion to either A or B 
yielded IEs that formed rosettes with  A+ and  AB+ erythrocytes, but not with  O+ erythrocytes (Fig. 2 and Supple-
mentary Table 1). These results support the importance of A and B blood group antigens in rosetting.
Adhesiveness of P. falciparum-infected erythrocytes to blood group A and B antigens is a sta‑
ble phenotype. The increase in IE adhesion to blood group A and B antigens following repeated panning 
of IEs on these receptors suggests that the adhesion is mediated by ligands encoded by members of one of 
the several multi-gene families in malaria parasites. While only limited information is available regarding the 
temporal stability of IE adhesion mediated by the STEVOR (~ 30 variants/parasite) and RIFIN antigens (~ 150 
variants/parasite), substantial variation is known to exist in the stability of adhesion mediated by members of 
the best-studied adhesion family PfEMP1 (~ 60 variants/parasite). To determine the stability of the blood group 
A- and B-adhering IE phenotypes, in vitro cultures of P. falciparum 3D7 that had been selected for IE adhesion 
to either receptor were maintained for extended periods without further selection. In both cases, the initial IE 
adhesion phenotype was essentially stable for more than three months (> 50 generations) after the last selection 
round (Fig. 3).
Plasmodium falciparum-infected erythrocytes selected for adhesion to A and B blood group 
antigens bind better to endothelial cells than unselected infected erythrocytes. Expression of 
ABO antigens is not restricted to erythrocytes, but is also widespread on vascular endothelium, where they are 
potential receptors for sequestering IEs. We therefore proceeded by comparing the ability of unselected IEs and 
IEs selected for adhesion to blood group A and B to adhere to cell lines and human primary endothelial cells. 
Erythrocytes infected by P. falciparum 3D7 (Fig. 4) or FMG (Supplementary Fig. 4A) and selected for adhesion 
to blood group A or B showed increased adhesion to primary human aortic and foreskin endothelial cells and 
to the choriocarcinoma cell line BeWo, compared to unselected IEs. In contrast, selected IEs did not bind better 
than unselected IEs to wild-type Chinese hamster ovary (CHO) cells (CHO-K1), to K1-derived glycosylation 
mutants A745 and D677, or to K1 cells transfected to express known P. falciparum adhesion receptors CD36 or 
CD54 (ICAM-1) (Supplementary Fig. 5).
Plasmodium falciparum HB3-IEs, which we were unable to select for increased IE adhesion to ABO antigens, 
adhered to the tested human endothelial cells to approximately the same degree as P. falciparum 3D7 and FMG 
after selection (Supplementary Fig. 4B).
Selection of P. falciparum-infected erythrocytes for adhesion to A and B blood group antigens 
does not lead to major qualitative changes in var gene transcription. We next considered whether 
IE selection for adhesion to A and B antigens caused qualitative changes and/or quantitative increases in the 
transcription of genes encoding adhesive parasite ligands that could explain the increased IE adhesion to these 
receptors. As PfEMP1 appears to be the major IE adhesion ligands, we first compared levels of PfEMP1-encod-
ing var gene transcripts in P. falciparum 3D7 and FMG before and after selection. Selection of IEs for increased 
adhesion to BSA-A and BSA-B tended to cause a reduction in the level of var gene transcripts relative to tran-
scripts of housekeeping genes for both the tested parasites (Fig. 5, Supplementary Fig. 6). Although unselected 
Figure 2.  Formation of rosettes after selection for IE adhesion to ABO antigens. Frequency of rosettes formed 
by adhesion of uninfected blood group O, A, or AB erythrocytes to erythrocytes infected with late-stage P. 
falciparum 3D7 (A), FMG (B), or FUP (C) before selection (white) or after selection of IEs for adhesion to 
BSA-A (red) or BSA-B (blue). Data from one out of two independent experiments with similar results are 
shown.
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Figure 3.  Temporal stability of IE adhesion phenotype following selection. Adhesion of P. falciparum 3D7-IEs 
to BSA (circles) or BSA-A (diamonds) (A), or to BSA-H (triangles) or BSA-B (squares) (B) at various time-
points following selection for IE adhesion to BSA-A (red symbols) or BSA-B (blue symbols). Individual data 
points (symbols), regression lines (heavy lines), and 95% confidence intervals for regression lines (thin lines) are 
shown.
Figure 4.  Adhesion of IEs to cellular receptors. Adhesion of erythrocytes infected with late-stage P. falciparum 
3D7 to monolayers of aorta endothelial cells (EC), foreskin EC, BeWo choriocarcinoma cells, or uncoated wells 
(No cells) before (white) and after four rounds of selection on BSA-A (red) or BSA-B (blue), respectively. Error 
bars indicate standard deviations of mean results from four (No cells, Aorta EC, Foreskin EC) or three (BeWo 
cells) independent assays. Statistically significant differences (P < 0. 05) of post-hoc pairwise comparisons 
(Holm-Sidak method) following 1-way ANOVA (P < 0.01) are indicated by lines along the top of the panel.
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and selected parasites alike were predominantly ring stages, as evidenced by microscopy and 10–30 × increases 
in transcript number of the ring stage-specific gene sbp-131, fold increases tended to be lower for selected than 
for unselected parasites. Therefore, we cannot formally rule out that the apparent down-regulation was at least 
partially due to differences in the proportion of ring-stage parasites in the unselected versus the selected para-
sites. This notwithstanding, all data presented were obtained from a time point (15–16 h post-invasion), where 
transcription of both var and rif genes is  active32.
We observed no qualitative differences in the transcription of individual var genes (Supplementary Data), or 
in the relative proportions of transcribed genes in the structural var gene groups A, B, C, and E (Fig. 5 and Sup-
plementary Fig. 6) that could explain the change in IE adhesion before and after selection. We were thus unable to 
substantiate the hypothesis that the observed increased IE adhesion to A and B blood group antigens in response 
to in vitro selection is due to changes in transcription of var genes encoding particular PfEMP1 adhesion ligands.
Selection of P. falciparum-infected erythrocytes for adhesion to A and B blood group antigens 
does not lead to major qualitative changes in rif gene transcription. Particular RIFIN variants 
have also been implicated as parasite ligands involved in IE rosetting, and therefore by implication in endothe-
lial IE  adhesion17,18,33. We therefore proceeded to compare the levels of rif gene transcripts in P. falciparum 3D7 
before and after selection. As for the var genes, selection tended to result in a reduction in rif gene transcript 
levels, in the absence of major qualitative differences at the level of individual genes or the proportion of genes 
in the structural rif gene groups A and B (Fig. 6, Supplementary Fig. 7). Increased IE adhesion to A and B blood 
group antigens in response to in vitro selection thus does not appear due to changes in rif transcription.
Selection of P. falciparum-infected erythrocytes for adhesion to A and B blood group anti‑
gens does not affect immune IgG recognition of the parasite ligands expressed on the IE sur‑
face. Rosetting has repeatedly been associated with severe P. falciparum malaria. Furthermore, protective 
immunity to the disease has been associated with acquisition of IgG specific for parasite antigens on the sur-
face of IEs, and acquired protection against severe disease generally precedes protection against uncomplicated 
malaria and asymptomatic infection. On this basis, we hypothesized that selection for IE adhesion to ABO anti-
gens would lead to increased recognition of the IEs by IgG from semi-immune individuals living in areas with 
stable transmission of P. falciparum parasites. To test this, we labelled unselected IEs and IEs selected for adhe-
sion to blood group A and B antigens with plasma IgG from 93 Ghanaian children with P. falciparum malaria. 
For all the tested parasites (3D7, FMG, and HB3), the median IE recognition by immune plasma IgG was similar 
for unselected, BSA-A- and BSA-B-selected IEs (Fig. 7). Furthermore, immune IgG recognition of unselected 
and selected IEs were very significantly correlated for all three parasite lines (0.65 < r < 0.93; 1 × 10–12 < P < 1 × 10–
42 for all comparisons). Recognition of different parasite lines selected the same way generally correlated much 
less well (0.08 < r < 0.64; 0.5 < P < 1 × 10–12 for all comparisons of parasites selected the same way). We thus found 
Figure 5.  Transcription of var genes. Transcription of var genes in ring-stage P. falciparum 3D7 before (left) 
and after selection × 3 for IE adhesion to BSA-A (centre) or BSA-B (right). Genes are sorted according to 
structural groups 79 and to the transcript levels of individual genes relative to housekeeping gene in unselected 
parasites (this order is maintained in all panels). The size of the pies reflect the overall transcript levels relative 
to housekeeping genes. The var gene pf130003 is identified by an asterisk (*). For additional details regarding 
individual genes, see Supplementary Data.
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no evidence that selection for increased IE adhesion to blood group A or B antigens led to increased IE recogni-
tion by immune IgG, or to a different recognition pattern.
Discussion
The majority of severe and fatal episodes of P. falciparum malaria occurs among young children in equatorial 
Africa. The resulting selection pressure on the human population has led to mutations and adaptations that 
confer some degree of clinical protection. Classical examples include sickle-cell anaemia and  thalassaemia34,35. 
The ABO blood group antigens have also been implicated as determinants of malaria susceptibility, as blood 
group O appears to offer some degree of  protection36. The association has mainly been attributed to the prefer-
ential involvement of the non-O blood group antigens in  rosetting20. Rosetting can lead to vascular obstruction 
and endothelial inflammation, but likely also serves as a marker of adhesion of IEs to endothelial host receptors 
(sequestration), as blood group antigens are also widely expressed on vascular  endothelium37.
Figure 6.  Transcription of rif genes. Transcription of rif genes in ring-stage P. falciparum 3D7 before (left) and 
after selection × 3 for IE adhesion to BSA-A (centre) or BSA-B (right). Genes are sorted according to  types77 (A: 
red; B: blue; uncharacterized: yellow) and to the transcript levels of individual genes relative to housekeeping 
gene in unselected parasites. The size of the pies reflect the overall transcript levels relative to housekeeping 
genes. For details regarding individual genes, see Supplementary Data.
Figure 7.  Immune IgG recognition of IEs. Immune IgG recognition of erythrocytes infected with late-stage P. 
falciparum 3D7 (A), FMG (B), or HB3 (C) before (white) and after four rounds of selection on BSA-A (red) or 
BSA-B (blue), respectively. Medians (centre lines), central 50% (boxes), central 90% (error bars), and outliers 
(circles) of levels of IgG in individual plasma samples from 93 Ghanaian children with P. falciparum malaria 
are shown. Recognition of the IEs by IgG in a pool of plasma from non-exposed donors was always < 5.5 (3D7) 
or < 1.5 (FMG and HB3).
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Analysis of the role of ABO blood group antigens in malaria pathogenesis is complicated by the many other 
endothelial receptors known or suspected to be involved in sequestration, and by the high number and diversity 
of the parasite molecules that serve as sequestration ligands on  IEs38. In the present study, we therefore sought 
to study the contribution of ABO antigens to IE adhesion and rosetting in the absence of other host receptors 
present on erythrocytes and endothelial cells. We also sought to gain insights regarding the parasite ligands 
mediating rosetting and sequestration.
To achieve this, we used five P. falciparum lines/clones (3D7, FCR3, FMG, FUP, and HB3) and commercially 
available BSA neo-glycoproteins, engineered to selectively display the H carbohydrate antigen (blood group O; 
BSA-H), blood group A antigen (BSA-A), or blood group B antigen (BSA-B). All the IEs used in our study ini-
tially showed minimal adhesion to each of the tested neo-glycoproteins (Fig. 1, and Supplementary Fig. 1). All 
except FCR3 and HB3 could be selected by repeated panning of IEs on BSA-A or BSA-B for markedly increased 
IE adhesion to these receptors. In contrast, attempts to select for increased adhesion to BSA-H (only 3D7) were 
unsuccessful. HB3 is genetically distinct from FCR3, whereas FCR3 is derived from  FMG39, which responded 
rapidly to selection on BSA-A and BSA-B by changing its IE adhesion phenotype. FCR3 thus appears to have lost 
part(s) of its genome that is required for IE adhesion to ABO antigens. Alternatively, switching to that phenotype 
is for some reason a rare event in FCR3. Blood group O erythrocytes can form rosettes around IEs, but they tend 
to be smaller and weaker than rosettes involving A, B, or AB  erythrocytes20,40. Several erythrocyte antigens have 
been implicated as receptors in  rosetting41, and the most parsimonious explanation for our inability to select 
IEs for adhesion to the H antigen that defines blood group O is that the receptor mediating rosetting of blood 
group O erythrocytes is not the H antigen.
In our hands, selection on either BSA-A or BSA-B resulted in increased IE adhesion to both receptors (Fig. 1, 
and Supplementary Fig. 1) and in increased rosetting rates with both blood group A and blood group AB eryth-
rocytes (Fig. 2). To our knowledge, selection for IE adhesion to ABO antigens in the absence of other potentially 
interfering receptors has not been reported before, but our results agree with reports implicating both blood 
group A and B antigens in  rosetting20. The strong co-selection for IE adhesion to both A and B oligosaccharides 
by panning on either receptor indicates that the same parasite ligand(s) can bind both antigens, although this may 
not always be the  case42. In addition to increased IE adhesion to BSA-A and BSA-B, selection on these receptors 
also lead to increased IE adhesion to several human cell lines (Fig. 4 and Supplementary Fig. 4). In contrast, the 
selection had little impact on IE adhesion to a range of CHO cells (Supplementary Fig. 5), including various 
glycosylation mutants and cells transfected to express human CD36 or ICAM-1, which are known P. falciparum 
IE adhesion  receptors22,43. These findings support the hypothesis that the association between rosetting and severe 
malaria is not only mediated by rosetting per se, but also involves IE adhesion to  endothelium12.
Proteins encoded by several parasite multi-gene families and expressed on the IE surface have been implicated 
in IE rosetting and endothelial  adhesion38. We therefore sought to determine the role of these in the increased 
IE adhesiveness to BSA-A and BSA-B following selection. We first considered the PfEMP1 antigens, which are 
encoded by the approximately 60 var genes per genome. PfEMP1 is a key element in the characteristic clonal 
antigenic variation of P. falciparum that endows this species with the capacity for rapid changes in the antigenic 
and adhesive characteristics of  IEs44–46. Furthermore, IE adhesion to a number of endothelial host receptors, 
including CD36, ICAM-1 (CD54), chondroitin sulphate A, and endothelial protein C receptor, has been attrib-
uted to particular PfEMP1  variants47–50. Severe disease is largely restricted to P. falciparum (where it has been 
associated with  rosetting8–10, and although malaria-infected erythrocytes are generally able to form  rosettes2,4–7, 
P. falciparum is the only malaria parasite infecting humans that possesses this type of antigens. Finally, PfEMP1 
is believed to be the main target of naturally acquired protective antibodies targeting the IE  surface51,52. Despite 
all these indicators, we did not find evidence of a marked change in var gene transcription profiles (Fig. 5 and 
Supplementary Fig. 6) that could explain the marked changes in IE adhesion to BSA-A and BSA-B (Fig. 1 and 
Supplementary Fig. 1) and in IE rosetting rates (Fig. 2) following selection for IE adhesion to blood group A 
and B. The only noteworthy difference observed was an increase in the proportion of pf13_0003 transcripts fol-
lowing selection (Fig. 5). However, the change appears insufficient to explain the marked phenotypic response 
to selection, despite the fact that the PfEMP1 encoded by pf13_0003 (and other genes with orthologous DBL1α 
domains, such as varO and it4var9) has previously been implicated in  rosetting14,53,54. Indeed, transcription of 
it4var9 appeared to be very low and did not change in response to selection (Supplementary Fig. 6 and Supple-
mentary Data). The same was true for it4var60, another var gene implicated in rosetting through blood group 
A and other  receptors16. Overall, IE selection for adhesion to blood groups A and B on var gene transcription 
tended to cause down-regulation relative to transcription of housekeeping genes (Fig. 5, Supplementary Fig. 6). 
The second major multi-gene family encoding antigens implicated in IE rosetting and adhesion to ABO antigens 
is rif18,55. However, the rif gene transcriptional response to IE selection for adhesion to ABO antigens was also 
minimal, apart from a similar tendency towards overall down-regulation (Fig. 6 and Supplementary Fig. 7). For 
both gene families, it cannot be formally excluded that this was related to a less stringent dominance of ring 
stages in the selected populations analysed.
The repertoire of P. falciparum-IE surface-reactive plasma IgG varies markedly with age, exposure, and level 
of clinical immunity to  malaria56–60. Furthermore, in vitro selection of IEs for adhesion to specific host receptors 
can lead to dramatic changes in the IgG recognition of IEs—changes that correlate with the clinical immune status 
of the IgG  donor61,62. These findings indicate that IE adhesion is mediated by parasite-encoded variant antigens 
on the IE surface, and has led to the identification of PfEMP1 and RIFIN proteins that are selectively expressed 
by IEs with defined adhesion  phenotypes18,48–50,63. Despite this, we found here that IgG-specific recognition of 
IEs before and after selection for adhesion to ABO antigens were remarkably similar (Fig. 7).
There are several possible explanations for our findings. One is that IE adhesion to blood group sugars is 
not mediated by members of the variant surface antigen families PfEMP1 and RIFINs. Instead, it might involve 
variant antigens not studied here, e.g.,  STEVOR19,64,65, or unidentified conserved antigens. Our study has little 
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to offer with respect to the former of these alternatives. With respect to the latter, our selection for IE adhesion 
to ABO antigens might conceivably have favoured parasites with reduced expression of PfEMP1 and/or RIFIN 
proteins, which would otherwise interfere with the functionality of the unknown parasite ligand. The absence 
of a serological response to the selection might reflect an increased IgG response to that ligand that offset a 
reduced IgG recognition of PfEMP1 and RIFIN antigens. However, the marked reduction in IgG reactivity with 
the IE surface if PfEMP1 expression is selectively  disrupted52 can be seen as an argument against this hypothesis. 
Furthermore, the fact that erythrocytes infected by parasites recovered from severely ill patients tend both to be 
particularly well recognized by plasma  IgG59,60 and to form  rosettes8,10 is difficult to explain under this hypothesis.
Another possibility that potentially overcomes the above difficulties is that IE adhesion to ABO antigens 
depends on post-translational modifications of variant antigens. These modifications might enable increased 
IE adhesion to ABO antigens despite reduced VSA expression. Although this idea is currently unsupported by 
direct evidence, it is consistent with our findings. The remarkable—and somewhat surprising—temporal stabil-
ity of the selection-induced change in IE adhesion to ABO antigens (Fig. 3) can also be accommodated in this 
scenario, if these putative modifications are assumed not to be restricted to particular members or types within 
the affected variant antigen families. Finally, the hypothesis is compatible with the bulk of the evidence available 
in the literature, and thus deserves further study.
In conclusion, we have shown that the study of IE adhesion to ABO blood antigens in the absence of other, 
potentially confounding host receptors can improve our understanding of the processes and molecules involved 
in IE sequestration and rosetting, two central elements in the pathogenesis of P. falciparum malaria.
Methods
Plasmodium falciparum malaria parasites. Five P. falciparum lines/clones were used in the experi-
ments reported here. 3D7 is a clonal derivative of an isolate (NF54) originally obtained from a malaria patient in 
the  Netherlands66. P. falciparum FMG was originally obtained from a Gambian patient, and is the parent of the 
widely used FCR3  line39. HB3 is a clonal derivative of an isolate from  Honduras67, while FUP is a line originally 
obtained by inoculation of Aotus monkeys with blood from a patient returning from Uganda, and subsequently 
adapted to in vitro  culture68. All the parasites were maintained in type O erythrocytes in RPMI-1640 medium 
supplemented with Albumax II, as described in detail  elsewhere69. Late-stage (trophozoite/schizont) IEs were 
purified by magnet-activated cell sorting as described  previously70, except that RPMI-1640 was used throughout. 
To rule out cross-contamination among the lines, or unintentional outgrowth of minor genotypes in non-clonal 
lines, we regularly verified the genotype of our cultures by monitoring line-specific polymorphisms in the MSP1 
and MSP2  loci71.
Cell lines. Primary human endothelial cells obtained from aorta and dermis of foreskin, and the choriocarci-
noma cell line BeWo, were cultured in vitro according to recommended procedures as described  elsewhere72,73. 
Chinese hamster ovary (CHO) cell lines A745, D677, K1 and K1-derived transgenic lines expressing human 
CD36 and CD54 (ICAM-1), respectively, were cultured in vitro as previously  described73.
ABO blood group oligosaccharides. Blood group A tri-saccharide with 6-atom spacer (NGP6305), 
blood group B tri-saccharide with 6-atom (NGP6323) or 3-atom (NGP0323) spacer, and blood group O (H) 
di-saccharide with 3-atom spacer (NGP0205), all coupled to bovine serum albumin (BSA), were obtained from 
Dextra, UK (https ://dextr auk.com/). The ability of the constructs to bind and present the relevant oligo saccha-
ride epitopes were confirmed with human ABO-specific, biotinylated plant lectins, and with A- and B-specific 
mouse monoclonal antibodies (Sigma SAB4700677 and SAB4700676, respectively) (Supplementary Fig. 8).
in vitro selection of P. falciparum parasites for infected erythrocyte adhesion to ABO blood 
group antigens. ABO blood group saccharide-coupled BSA (10 µg/mL) was used to coat 24-well standard 
culture plates (400 µL/well, overnight, 4 °C). The wells were subsequently blocked with BSA (20 mg/mL, 2 h, 
room temp.), and washed × 3 in parasite culture medium. Purified late-stage IEs (~ 1 × 108/mL) were added to 
the wells (400 µL/well) and incubated on a shaking table (60 min, room temp., 100 RPM). Unbound IEs were 
removed by gentle washing (×4 to ×6) with parasite culture medium (1 mL/wash) without initial removal of 
400 µL. The wells were inspected using an inverted microscope after every other wash, to optimize enrichment of 
adherent IEs). After the final wash, parasite culture medium (500 µL/well) and uninfected erythrocytes (40 µL/
well) were added to the plates, which were then incubated overnight under standard parasite culture conditions 
to allow reinvasion, followed by transfer to standard culture flasks and further propagation.
Infected erythrocyte adhesion assays. The ability of IEs to adhere to ABO blood oligosaccharides and 
to cells was measured essentially as described  previously72. Assays were done in 96-well Polysorb plates, coated 
(50 µL/well) and blocked (150 µL/well) as described for the selection procedure (BSA constructs), or in 96-well 
flat-bottomed tissue culture plates (cells), in which monolayers of the relevant cell type had been seeded approxi-
mately 48 h before. Wells with the appropriate cell culture medium but without cells were always included as 
negative controls. Purified late-stage IEs (1–2 × 107/mL, 100 µL/well) were added to duplicate (adhesion to ABO 
constructs) or triplicate wells (adhesion to cells), and incubated (30 min on a shaking table as above). After the 
incubation, the plates were placed upside-down in a container with PBS (2% foetal calf serum; 60 min; room 
temp.) to allow unbound IEs to sink to the bottom of the container under gravity only. The plates were subse-
quently removed from the container, dried with paper tissue, followed by lysis of bound IEs by addition of PBS 
(100 µL/well), supplemented with Triton-X-100 (1% v/v). A separate preparation of lysed IEs (same number 
and batch as used in the adhesion assay) was then added to two previously empty wells (total_IEs). Adherent 
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IEs (adh_IEs) were quantified by adding tetramethylbenzidine (100 µL/well) ELISA substrate and measuring 
the optical density (OD) of wells at 450 nm in a standard ELISA reader. The enzymatic reaction was stopped 
with sulphuric acid (1 M) while  ODtotal_IEs < 2 to ensure a linear relationship between the number of IEs OD. The 
fraction of IEs adhering was calculated as  (ODadh_IEs − ODbackground)/(ODtotal_IEs − ODbackground), where  ODbackground 
was the mean OD obtained in wells, where IEs had not been added. In assays measuring IE binding to cells, the 
background wells were seeded with the appropriate cells.
The ability of anti-A and anti-B antibodies to inhibit IE adhesion to BSA-A and BSA-B was tested using 
saturating concentrations of the above-mentioned monoclonal antibodies.
Rosetting assays. Purified late stage-IEs were mixed with uninfected erythrocytes with different ABO 
types. Incubation, staining with ethidium bromide and reading of the assays were as described  previously26.
Assessment of human IgG reactivity with variant surface antigens on infected erythro‑
cytes. Purified late stage-IEs (1 × 105/plasma sample) were first incubated with human immune plasma (5 µL; 
30 min; room temp.), obtained from 93 ABO-typed (with commercially available agglutination kits (Fortress 
Diagnostics, UK)) children with acute P. falciparum malaria, living in an area of high and seasonal transmission 
of P. falciparum  parasites74. Further processing and quantification of IgG binding to IEs by flow cytometry were 
essentially as described  previously75, using FlowLogic software (https ://www.iniva i.com/).
var and rif gene transcription profiling. Parasite cDNA was generated from DNA-free total RNA pre-
pared from ring-stage IEs (approximately 15–16 h post-invasion) and using SuperScript II reverse transcriptase 
and random primers, according to the manufacturer’s instructions (https ://therm ofish er.com). Levels of var and 
rif gene transcripts were measured using cDNA, QuantiTec SYBR Green PCR Master Mix (Qiagen), and gene-
specific primer pairs for 58 (3D7)76 and 56 (FMG)71 var genes, 154 rif genes (3D7)77,78, and for the endogenous 
control genes seryl-tRNA synthetase (p90) and fructose-bisphosphate aldolase (p61)76. Transcript copy number 
of each gene in tested cDNA was calculated using quantitative measurements of tenfold dilutions of genomic 
DNA as previously  described78.
Statistical analysis. The statistical significance of intergroup differences were first tested by 1-way analysis 
of variance. If that yielded a statistically significant (P < 0.05), statistically significant (P < 0.05) pairwise differ-
ences were identified by the Holm-Sidak method.
Ethics statement. The work described here was conducted in accordance with all relevant guidelines and 
regulations, and all donors provided their informed consent to participate prior collection of blood samples. The 
experimental protocols (including collection of the human blood samples used), were approved by the Ethics 
Committee of the Noguchi Memorial Institute for Medical Research, University of Ghana, by Ghana Health Ser-
vice (GHS-ERC 08/05/14), and by the Regional Research Ethics Committees for the Capital Region of Denmark 
(Protocol H-4-2013-083).
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